Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Citi
US Army
Covington
Accenture
Mallinckrodt

Generated: April 21, 2019

DrugPatentWatch Database Preview

Zydus Pharms Usa Company Profile

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS USA, and when can generic versions of ZYDUS PHARMS USA drugs launch?

ZYDUS PHARMS USA has one hundred and ninety-eight approved drugs.

There is one US patent protecting ZYDUS PHARMS USA drugs. There are nine tentative approvals on ZYDUS PHARMS USA drugs.

There are two patent family members on ZYDUS PHARMS USA drugs in two countries and two hundred and ninety supplementary protection certificates in fourteen countries.

Summary for Zydus Pharms Usa
International Patents:2
US Patents:1
Tradenames:166
Ingredients:165
NDAs:198

Drugs and US Patents for Zydus Pharms Usa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM amlodipine besylate; atorvastatin calcium TABLET;ORAL 207762-010 Jan 11, 2019 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc CLOPIDOGREL BISULFATE clopidogrel bisulfate TABLET;ORAL 201686-001 Oct 10, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 078243-001 Oct 6, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc BUSPIRONE HYDROCHLORIDE buspirone hydrochloride TABLET;ORAL 078888-002 Feb 7, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03

Supplementary Protection Certificates for Zydus Pharms Usa Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0300652 C300117 Netherlands ➤ Try a Free Trial PRODUCT NAME: DEXMEDETOMIDINE, DESGEWENST IN DE VORM VAN EEN NIET-TOXISCH IN FARMACEUTISCH OPZICHT AANVAARDBAAR ZUURADDITIEZOUT, IN HET BIJZ ONDER DEXMEDETOMIDINE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/2/02/033/001 20020830
1519731 92269 Luxembourg ➤ Try a Free Trial PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE
1412357 PA2008013 Lithuania ➤ Try a Free Trial PRODUCT NAME: SITAGLIPTINUM PHOSPHAS MONOHYDRICUS, METFORMINI HYDROCHLORIDUM; REG. NO/DATE: EU/1/08/455/001-014 20080716
1003503 30/2006 Austria ➤ Try a Free Trial PRODUCT NAME: AMLODIPIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SAEUREADDITIONSALZ DESSELBEN IN KOMBINATION MIT ATORVASTATIN ODER EINEM PHARMAZEUTISCH ANNEHMBAREN SALZ DESSELBEN; NAT. REGISTRATION NO/DATE: 1-26271, 1-26273 20060330; FIRST REGISTRATION: FR 369300.9;369301.5; 369302.1;369303.8;369304.4;369305.0; 20050707
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKesson
Healthtrust
US Army
McKinsey
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.